Short Interest in Vicarious Surgical Inc. (NYSE:RBOT) Expands By 23.2%

Vicarious Surgical Inc. (NYSE:RBOT) was the target of a significant growth in short interest in February. As of February 13th, there was short interest totaling 383,672 shares, a growth of 23.2% from the January 29th total of 311,456 shares. Based on an average daily trading volume, of 61,595 shares, the days-to-cover ratio is presently 6.2 days. Currently, 6.5% of the company’s stock are sold short. Currently, 6.5% of the company’s stock are sold short. Based on an average daily trading volume, of 61,595 shares, the days-to-cover ratio is presently 6.2 days.

Vicarious Surgical Price Performance

Shares of RBOT stock traded up $0.07 on Tuesday, hitting $1.99. The company’s stock had a trading volume of 53,787 shares, compared to its average volume of 65,261. The stock has a market capitalization of $13.00 million, a price-to-earnings ratio of -0.22 and a beta of 1.54. Vicarious Surgical has a fifty-two week low of $1.71 and a fifty-two week high of $13.75. The firm’s fifty day moving average price is $2.21 and its 200-day moving average price is $3.96.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on RBOT shares. Weiss Ratings restated a “sell (e+)” rating on shares of Vicarious Surgical in a research report on Wednesday, January 21st. Wall Street Zen upgraded shares of Vicarious Surgical from a “sell” rating to a “hold” rating in a report on Sunday, February 8th. Finally, BTIG Research reaffirmed a “neutral” rating on shares of Vicarious Surgical in a research report on Friday, December 12th. Two research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $7.00.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in RBOT. DNB Asset Management AS raised its position in shares of Vicarious Surgical by 12.1% in the second quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after purchasing an additional 3,154 shares during the period. Dimensional Fund Advisors LP grew its stake in Vicarious Surgical by 22.1% in the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock valued at $110,000 after buying an additional 3,615 shares during the last quarter. Connective Capital Management LLC bought a new position in Vicarious Surgical in the 3rd quarter worth $169,000. Geode Capital Management LLC raised its holdings in Vicarious Surgical by 26.0% in the 4th quarter. Geode Capital Management LLC now owns 40,494 shares of the company’s stock worth $88,000 after acquiring an additional 8,344 shares during the period. Finally, Jane Street Group LLC acquired a new position in Vicarious Surgical during the 4th quarter worth $98,000. 47.27% of the stock is owned by institutional investors.

Vicarious Surgical Company Profile

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.